
Loss of an EGFR-amplified chromosome 7 as a novel mechanism of acquired resistance to EGFR-TKIs in EGFR-mutated NSCLC cells
Keywords: سرطان ریوی غیر سلول کوچک; Erlotinib; EGFR-TKI; Mutation; Resistance; Non-small cell lung cancer; NSCLC;